Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01934491 · ClinicalTrials.gov registry record · NA
Cognitive Training for Depression II
A NA study of Major Depressive Disorder, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
- 1
- Study location
NCT01934491: Completed NA study of Major Depressive Disorder, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01934491 is a NA study of Major Depressive Disorder that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 51 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01934491, a NA study of Major Depressive Disorder, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.
Primary Outcome
Depression symptom severity comparison at week 6 to baseline
Conditions Studied
Interventions
- BEHAVIORAL Cognitive Training A
- BEHAVIORAL Cognitive Training B
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-05-16 |
| Phase | NA |
What the finished NCT01934491 record still lists
NCT01934491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Training A is the first listed.
NCT01934491 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01934491 about?
NCT01934491 is a clinical study titled "Cognitive Training for Depression II". This study is evaluating the effects of two brain training exercises on: memory, cognitive processing and depression symptoms.
What is the current status of trial NCT01934491?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2013-08. Estimated completion is 2017-05-16.
What conditions does trial NCT01934491 study?
This clinical trial studies the following conditions: Major Depressive Disorder.
What interventions are being tested in trial NCT01934491?
The interventions under investigation include: Cognitive Training A (BEHAVIORAL), Cognitive Training B (BEHAVIORAL).
Who is sponsoring clinical trial NCT01934491?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01934491 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01934491's enrollment target sits among peer trials
51 182nd of 282 higher than 101 of 282 other Major Depressive Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
RECRUITING · NA
-
Neural Correlates of Stress and Perceived Control in Adolescent Depression
RECRUITING · NA
-
Positive Processes and Transition to Health (PATH)
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Amygdala Neurofeedback for Depression - Large Scale Clinical Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia